In patients with hematological diseases complicated by neutropenia, Candida and Aspergillus infections are commonly described. However, over the last few years, opportunistic infections due to multi-resistant fungi have been increasingly reported. We describe here a fatal case of disseminated Scopulariopsis brevicaulis infection in an allogenic stem cell recipient.
In January 2007, a 43-year-old woman was diagnosed with myelodysplasia. In March 2008, she developed secondary AML. In July 2008, induction chemotherapy with a classical 3 þ 7 regimen failed to induce CR and a second induction course of chemotherapy induction was administered with anthracycline and high-dose cytarabine. The chemotherapy resulted in a prolonged period of profound neutropenia.
The patient's fever was addressed by empirical broadspectrum antibiotherapy. Finally, she achieved CR and fever resolved without any infection being documented. In October 2008, the patient underwent allogeneic PBSC transplantation from an unrelated donor. GVHD prophylaxis with corticosteroids and mycophenolate mofetil was used. In November 2008, computed tomography (CT) showed a lesion in the upper right lung suggestive of pulmonary aspergillosis. Treatment by voriconazole (200 mg Â 2/day) was started. On 2 February 2009, the patient developed chronic neutropenia and treatment by vesanoid was then initiated. On 8 February 2009, she developed temperature, with chest pain, coughing and progressive dyspnea. Voriconazole was continued and large-spectrum antibiotherapy (tazocillin, gentamicin and zyvoxid) was added. Aspergillus antigenemia was negative; no bacteria or viruses were found in the blood, urine or after catheter culture. On 20 February 2009, due to the persistence of respiratory symptoms and fever, whole-body CT was performed, revealing destruction of the posterior wall of sphenoidal sinus, infiltrate in the upper right lung and multiple intra-hepatic nodules. Zygomycosis was suspected, because of the lengthy voriconazole treatment (4 months) and the CT-detected lesion of the sinus. Voriconazole was replaced by liposomal 2 amphotericin B (10 mg/kg/day). Direct microscopical examination of the samples on 24, 26 and 27 February showed evidence of fungus mycelia. The sputum culture aroused suspicion of S. brevicularis on 4 March 2009. The molecular identification that allowed the formal identification was based on the ITS1 DNA sequence analysis of a fragment after PCR amplification based on the 28S ribosomal RNA sequence. In vitro study by the Etest method revealed high antifungal minimal inhibitory concentration (MIC): amphotericin B (2 mg/mL), posaconazole (1 mg/mL), itraconazole (32 mg/mL) and voriconazole (32 mg/mL). On 5 March, terbinafine (250 mg/day) was added to liposomal amphotericin B. MICs obtained by Etest were confirmed by the reference procedure of the European Committee on Antifungal Susceptibility (EUCAST) for spore-forming molds. Despite the antifungal treatment, the patient died 4 days later.
The genus Scopulariopsis mainly comes from soil, food and organic materials. The majority of Scopulariopsis human infections are due to S. brevicularis. It can cause onychomycosis and soft tissue infection after traumatic injuries. 1 In immunocompromised patients, cases are rare, but increasing. Eight cases, all of them concerning hematological patients, have been reported in medical publications. All of them were allogeneic transplanted patients with prolonged neutropenia (seven acute leukemia, one aplastic anemia). Furthermore, 5/8 had been on steroid therapy. In six cases, S. brevicularis infections were localized in the lung. The clinical presentation does not give many clues. Fever seems to have been persisting in all the cases despite large-spectrum antibiotherapy. Complaints of coughing and shortness of breath were observed in two cases. 2, 3 Tomography displayed pulmonary infiltrates (2/6), 2, 4 or pulmonary lesions evoking Aspergillus infection (3/6). [4] [5] [6] It is noticeable that in three cases [5] [6] [7] skin lesions appeared before the pulmonary symptoms arose. In two cases sinonasal localizations, diagnosed by biopsies, have been reported, 2 and in one case the sinus localization was linked to a brain abscess. 8 In the case of the patient described herein, the lung was affected. A sinusal dissemination 3 was suspected, but no biopsy was performed because of the localization of the lesion and no definitive conclusion was possible. Furthermore, Scopulariopsis fungemia had not been detected.
Concerning other non-Aspergillus fungal disseminated infections, it must be stressed that fungemia may be positive in Fusarium or Scedosporium infections. To our knowledge, Scopulariopsis-positive hemoculture has been reported in only one case. 7 As post-mortem examination was not performed, we do not know the origin of the hepatic nodules, but in two reported cases, autopsy showed disseminated infection in the lung, brain, kidney and liver. 2 In the present case, direct microscopical examinations and culture on repeated sputum samples led to the detection of mycelium. In medical publications, pulmonary infections are reported to be demonstrated by bronchoscopy (1/6) or lung biopsy (1/6). 4 We did not observe any onyxis or cutaneous lesion. However, as in other fungal infections, when cutaneous lesions are observed, skin biopsy can prove to be very useful (3/8 patients had positive biopsy). In vitro, Scopulariopsis is resistant to amphotericin B, itraconazole, fluconazole and flucytosine. Ten combinations of antifungal compounds were tested against 25 clinical isolates of S. brevicularis. Synergistic interaction was detected for posaconazole plus terbinafine. 9 In the reported cases in Hematology, the only patient who survived was treated by voriconazole plus terbinafin associated with surgery. 4 In the present case, since voriconazole prophylaxis had been demonstrated as an independent risk factor for zygomycosis, 10 we suspected zygomycosis at first, because of the 4-month treatment of voriconazole, and the negative Aspergillus galactomannan antigenemia. It is interesting to note that in the reported cases of Scedoporium infections, as in our case, two patients had received long-term antifungal treatment (itraconazole and posaconazole). Hence, we hypothesize that the azole treatment might contribute to the emergence of Scopulariopsis.
Invasive Scopulariopsis infection is an emerging disease among hematological patients with allogenic transplantation. Identification of Scopulariopsis by the analysis of respiratory samples may be the first step leading to a diagnosis. Surgical debridement in association with an antifungal treatment seems to be the most efficient method to cope with this commonly fatal infection.
